Home > Products > B Cell Lymphoma 38C13 Idiotype & CD44 > Recombinant Anti-B Cell Lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (scFv4-Ig)

Recombinant Anti-B Cell Lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (scFv4-Ig)  (CAT#: FVTIG-013)

Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-B cell lymphoma 38C13 Idiotype scFv is fused to the CH1 domain of a heavy chain and another anti-CD44 scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy.
Datasheet INQUIRY

Specifications

Targets
B Cell Lymphoma 38C13 Idiotype & CD44
Type
Appended IgGs
Species Reactivity
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma

Targets

Target 1
B Cell Lymphoma 38C13 Idiotype
Alternative Names
B cell lymphoma 38C13 Idiotype; B cell lymphoma; 38C13; Idiotype; Id
Target 2
CD44
Gene ID
UniProt ID
Alternative Names
CD44; CD44 antigen; ECMRIII; Extracellular matrix receptor III; HCAM; Homing cell adhesion molecule; Pgp-1; phagocytic glycoprotein-1; HUTCH-1; Ly-24; Pgp-1; HERMES; AU023126; AW121933; AW146109
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

See other bsAb targets related to "B Cell Lymphoma 38C13 Idiotype"

See other bsAb targets related to "CD44"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-B Cell Lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (scFv4-Ig) (FVTIG-013). Click the button below to contact us or submit your feedback about this product.